Rohit Sharma - Oct 19, 2022 Form 4 Insider Report for Zymergen Inc. (ZY)

Role
Director
Signature
/s/ Celeste Ferber, attorney-in-fact
Stock symbol
ZY
Transactions as of
Oct 19, 2022
Transactions value $
$0
Form type
4
Date filed
10/19/2022, 07:38 PM

Rohit Sharma is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Pursuant to the Agreement and Plan of Merger, dated as of July 24, 2022, by and among Ginkgo Bioworks Holdings, Inc., Pepper Merger Subsidiary Inc. and the Issuer, at the effective time of the merger, the reporting person resigned from the board of directors of the Issuer.